Patents Archives | Page 55 of 111

GII index to be released, Patent office’s Annual Report for the year 2017-2018 and more

“Patent News Bulletin: Indian Patent Statistics, Indian Industrial Design Statistics, Interesting Inventions, Global Innovation Index (GII) to be launched on 24th July, 2019 in New Delhi, CII’s is all set to take an exclusive IP delegation to Japan, in the month of August, The Office of CGPDTM and GI, India published the Annual Report for the year 2017-2018 and other news updates”, presented to you by the Patent attorneys and experts of BananaIP Counsels, India’s leading Patent Firm. Indian Patent…

July 22, 2019 BananaIP Reporter Intellectual Property, Patents 0Comment 4090Views 0Like

ShareFacebook

Patent Term Extension, Dog ate my Homework Act

This post was first published on 12th April, 2011. Guest Post by Ms. Vinita Radhakrishnan In future, 'Dog ate my homework' may be a perfectly accepted excuse for missing a deadline at United States Patent and Trademark Office (USPTO) for Patent term extension (PTE) request. Recently, I stumbled upon an article authored by Dianna Goldenson titled “A day late and a few million dollars short". The article mainly refers to the deadline calculation for the Patent term extension request to…

July 22, 2019 BananaIP Reporter Intellectual Property, Patents 0Comment 807Views 0Like

ShareFacebook

Patent Application for Acupuncture Needle

This post was first published on 5th April, 2011. On 6th November 1995, Tae. W Yoo of Seol from Korea filed a patent application (US 5624460) titled “Needle for Acupuncture”. Acupuncture is used as an alternative medicine, adapted from Chinese medical practices in which specific body areas are pierced with fine needles for therapeutic purposes. It can be used to treat or prevent disease. Acupuncture incorporates traditional Chinese medicine as an integral part of practice and theory. …

July 22, 2019 BananaIP Reporter Intellectual Property, Patents 0Comment 977Views 1Like

ShareFacebook

Patentability of Biotech Inventions in Europe

This post was first published on 22nd January, 2011. Patentable Subject Matter The discussion with respect to patentability of biotech inventions in Europe has been limited to the European Patent Convention (EPC). As per the European Patent Convention, any invention is patentable unless it falls within the list of excluded inventions. According to Article 52 of EPC, any invention irrespective of the technology to which it belongs can be considered as patentable subject matter so long as it is new,…

July 22, 2019 BananaIP Reporter Intellectual Property, Patents 0Comment 1748Views 0Like

ShareFacebook

Patentability of Biotechnology Inventions in India

Patentability of Biotechnology Continue Reading Patentability of Biotechnology Inventions in India

July 22, 2019 BananaIP Reporter Intellectual Property, Patents 0Comment 6195Views 0Like

ShareFacebook

Pop King’s Patent – The Lean Against Gravity

This post was first published on 23rd March, 2011. Michael Jackson will always be remembered as the King of pop and will always remain the greatest entertainer of all time. He thrilled everybody with his superb innovative dancing skills and inspired people to innovate their own unique style. He rollicked with his Moonwalk in Smooth Criminal. The moonwalk was earlier known as backslide, but it was Michael Jackson who made it famous after performing it in his song “Billie Jean”.…

July 22, 2019 BananaIP Reporter Intellectual Property, Media and Entertainment Law, Patents, Publicity Rights/ Celebrity Rights 0Comment 1313Views 0Like

ShareFacebook

This image depicts Tablets and Capsules of various colors. This image is relevant as the topic is about Final Guidelines for Examination of Pharmaceuticals Published. Click on the image for more information

Revised Draft Guidelines for Examination of Patent Applications in the Pharma Industry

This post was first published on 22nd August, 2014. The Controller General of Patents, Designs and Trademarks (CGPDTM) published the revised draft guidelines for the examination of patent applications in the field of Pharmaceuticals on August 12, 2014. The main intention of said guidelines was to bring in a uniform practice for the examination of patent applications relating to the Pharmaceutical field. Earlier in the month of February, the CGPDTM had published the draft guidelines with regard to this and had…

July 22, 2019 BananaIP Reporter Intellectual Property, Patents 0Comment 813Views 0Like

ShareFacebook

Smoking Without Smoke

This post was first published on 9th April, 2011. Smoking has become one of the biggest problems haunting youngsters today. Many of us know the famous scene from a Tamil movie starring Rajinikanth where Rajinikanth takes on the challenge of flipping his cigarette into the air and catching it with his mouth and repeats this ten times. Though, this kind of scenes get applauded by the audience in the theatre but when it comes to real life, smoking is considered to…

July 22, 2019 BananaIP Reporter Intellectual Property, Patents 0Comment 743Views 0Like

ShareFacebook

Patentability of Yoga- An Analysis

This post was first published on 22nd March, 2012. We are all aware that what is already existing in the public domain falls outside the scope of patentability. This is because it is already known and hence the aspect of novelty, which is the primary requirement to qualify for a patent is absent. Moreover, what is already there in the public domain cannot be taken back, because patents grant exclusivity to the inventor. Patenting of traditional knowledge is nothing new, and…

July 22, 2019 BananaIP Reporter Intellectual Property, Patents, Traditional Knowledge 0Comment 2437Views 0Like

ShareFacebook

The image depicts Cipla's range of veterinary products marked 'Advantage'. Another company has a similar mark 'Advantix' for the similar products. This post talks about how the trademark issue was settled. Click on the image to read the full post.

Trademark Litigation: ‘Advantage’ of Settlement

This post was originally published on 18th December, 2011. Bayer and Cipla have recently settled trade mark litigation with respect to Advantage and Advantix trade marks. These trade marks were registered by Bayer at the USPTO and are being used for veterinary products. Cipla has been marketing one of its pet products under the trade mark, DA Double Advantage with the aid of an online supplier called Archipelago. Aggrieved by Cipla's actions, Bayer filed a suit in a US court…